Skip to main content
Journal cover image

Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.

Publication ,  Journal Article
Adeniji, N; Arjunan, V; Prabhakar, V; Mannalithara, A; Ghaziani, T; Ahmed, A; Kwo, P; Nguyen, M; Melcher, ML; Busuttil, RW; Florman, SS ...
Published in: Liver Transpl
May 2021

The incidence of hepatocellular carcinoma (HCC) is growing in the United States, especially among the elderly. Older patients are increasingly receiving transplants as a result of HCC, but the impact of advancing age on long-term posttransplant outcomes is not clear. To study this, we used data from the US Multicenter HCC Transplant Consortium of 4980 patients. We divided the patients into 4 groups by age at transplantation: 18 to 64 years (n = 4001), 65 to 69 years (n = 683), 70 to 74 years (n = 252), and ≥75 years (n = 44). There were no differences in HCC tumor stage, type of bridging locoregional therapy, or explant residual tumor between the groups. Older age was confirmed to be an independent and significant predictor of overall survival even after adjusting for demographic, etiologic, and cancer-related factors on multivariable analysis. A dose-response effect of age on survival was observed, with every 5-year increase in age older than 50 years resulting in an absolute increase of 8.3% in the mortality rate. Competing risk analysis revealed that older patients experienced higher rates of non-HCC-related mortality (P = 0.004), and not HCC-related death (P = 0.24). To delineate the precise cause of death, we further analyzed a single-center cohort of patients who received a transplant as a result of HCC (n = 302). Patients older than 65 years had a higher incidence of de novo cancer (18.1% versus 7.6%; P = 0.006) after transplantation and higher overall cancer-related mortality (14.3% versus 6.6%; P = 0.03). Even carefully selected elderly patients with HCC have significantly worse posttransplant survival rates, which are mostly driven by non-HCC-related causes. Minimizing immunosuppression and closer surveillance for de novo cancers can potentially improve the outcomes in elderly patients who received a transplant as a result of HCC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Liver Transpl

DOI

EISSN

1527-6473

Publication Date

May 2021

Volume

27

Issue

5

Start / End Page

684 / 698

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Surgery
  • Risk Assessment
  • Retrospective Studies
  • Middle Aged
  • Liver Transplantation
  • Liver Neoplasms
  • Humans
  • Carcinoma, Hepatocellular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adeniji, N., Arjunan, V., Prabhakar, V., Mannalithara, A., Ghaziani, T., Ahmed, A., … Dhanasekaran, R. (2021). Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl, 27(5), 684–698. https://doi.org/10.1002/lt.25974
Adeniji, Nia, Vinodhini Arjunan, Vijay Prabhakar, Ajitha Mannalithara, Tara Ghaziani, Aijaz Ahmed, Paul Kwo, et al. “Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.Liver Transpl 27, no. 5 (May 2021): 684–98. https://doi.org/10.1002/lt.25974.
Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, et al. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl. 2021 May;27(5):684–98.
Adeniji, Nia, et al. “Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.Liver Transpl, vol. 27, no. 5, May 2021, pp. 684–98. Pubmed, doi:10.1002/lt.25974.
Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, Kwo P, Nguyen M, Melcher ML, Busuttil RW, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, Burcin Taner C, Hoteit MA, Verna EC, Halazun KJ, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo F, Nydam TL, Markmann JF, Mobley C, Ghobrial M, Langnas AN, Carney CA, Berumen J, Schnickel GT, Sudan DL, Hong JC, Rana A, Jones CM, Fishbein TM, Agopian V, Dhanasekaran R. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl. 2021 May;27(5):684–698.
Journal cover image

Published In

Liver Transpl

DOI

EISSN

1527-6473

Publication Date

May 2021

Volume

27

Issue

5

Start / End Page

684 / 698

Location

United States

Related Subject Headings

  • United States
  • Survival Rate
  • Surgery
  • Risk Assessment
  • Retrospective Studies
  • Middle Aged
  • Liver Transplantation
  • Liver Neoplasms
  • Humans
  • Carcinoma, Hepatocellular